Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 10, 2010
Mon, August 9, 2010 OPELF, BLXJF, JGBO, ONP, PCLI Have Been Added To Naked Short Lists Today
August 9, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. Opel International (OTC: OPELF), Boralex Power (OTC: BLXJF), Jiangbo Pharmaceuticals (NASDAQ: JGBO), Orient Paper (AMEX: ONP) and Protocall Technologies (OTC: PCLI). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Opel International Inc. (OTC: OPELF) engages in the design, manufacture, and marketing of high performance concentrating photovoltaic panels to transform solar energy into electricity in Canada and internationally. The company offers single and dual axis solar tracker systems to mount solar panels in ground mounted arrays or roof mounted systems; and infrared sensor type products for military and industrial applications. It also provides gallium arsenide-based processes and semiconductor microchip products; infrared sensor arrays for homeland security monitoring and imaging; and optical lasers and electronic control circuits on the same microchip for military programs and telecom applications, such as fiber to the home. The companya�s research and development activities relate to the commercialization of concentrating photovoltaic solar panels and solar trackers; and optical laser and infrared detection using planar opto electronic technology. It serves engineering, procurement, and construction firms; solar integrators interested in building large utility grade installations; and manufacturing companies, office buildings, large stores, and municipalities. Opel International Inc. was founded in 2000 and is headquartered in Toronto, Canada. There is a failure to deliver in shares of OPELF.
Boralex Power Income Fund (OTC: BLXJF) operates as an unincorporated open-ended limited purpose trust. The company, through its subsidiaries, engages in the generation, transmission, distribution, purchase, and sale of electricity and thermal energy, and its related activities. It generates energy from sources, including wood-residue or natural gas thermal and cogenerating facilities, as well as hydroelectric power stations. As of December 31, 2009, the company owned interest in 10 power generating facilities with an installed capacity of 190 megawatts, located in the Province of Quebec, Canada and in the state of New York, the United States. Its power generating facilities include 7 hydroelectric facilities, a wood-residue cogeneration power station, a wood-residue thermal power station, and a natural gas cogeneration power station. The company was founded in 1992 and is headquartered in Kingsey Falls, Canada. There is a failure to deliver in shares of BLXJF.
Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO) engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. The company produces tablets, capsules, granules, syrups, and electuary for western medical drugs and Chinese herbal-based medical drugs. Its principal products include Clarithromycin sustained-release tablets, which are semi-synthetic antibiotics for curing Clarithromycin sensitive micro-organism infections; Itopride Hydrochloride granule, a stomach and intestinal drug used for curing digestive system-related diseases; Ciprofloxacin Hydrochloride tablets, an antibiotic drug used to cure infection caused by bacteria; and Paracetamol tablets for curing fever due to common flu or influenza. The companya�s products also comprise Baobaole Chewable tablets for the treatment of gastric cavity aches and to cure deficiencies in the spleen and stomach, abdomen aches, loss of appetite, and loose bowels; Radix Isatidis Disperable tablets for the treatment of virus influenza and sour throat; New Compound Foliumisatidis tablets for the treatment of influenza symptoms; and Laiyang Pear Cough Syrup for the treatment of coughs rising from colds and other illnesses. In addition, it offers Kang Gu Sui Yan Pian tablets for the treatment of bone and bone marrow inflammations; Gan Mao Zhi Ke Ke Li, an antipyretic and antitussive granule that helps to relieve cold and flu symptoms; Yi Mu Cao Gao for the treatment of dysmenorrhoea, oligminorrhea, and postpartum abdominal pain; Ban Lan Gen Ke Li, a herbal-based Chinese medicine for the treatment of viral influenza; and Gan Mao Zhi Ke Tang Jiang for the treatment of fever, headache, rhinocleisis, cough, throat pain, and phlegm. Jiangbo Pharmaceuticals was formerly known as Genesis Pharmaceuticals Enterprises, Inc. and changed its name to Jiangbo Pharmaceuticals, Inc. in April 2009. The company was founded in 2003 and is based in Yantai, the People's Republic of China. There is a failure to deliver in shares of JGBO.
Orient Paper, Inc. (AMEX: ONP), through its subsidiary, Hebei Baoding Orient Paper Milling Company Limited, engages in the production and distribution of paper and paper products in the Peoplea�s Republic of China. The company offers various paper products, such as corrugating medium paper, offset printing paper, writing paper, and other paper and packaging related products. Orient Paper, Inc. markets its products primarily to cardboards producers and printing companies. The company was founded in 1996 and is headquartered in Baoding City, the Peoplea�s Republic of China. There is a failure to deliver in shares of ONP.
Protocall Technologies Incorporated (OTC: PCLI), together with its subsidiaries, develops and commercializes an electronic sell-through platform that enables retailers to produce DVD movie, consumer software, and video game products in retail packaging at their stores and Website distribution centers. It offers TitleMatch DVD On-Demand service that is designed to offer retailers a virtual inventory of digital media products, which can be produced on-demand, thereby eliminating the cost of physical inventories. The company also uses its service to provide outsourced fulfillment services to Web retailers whereby digital media product orders are electronically routed to the company for on-demand production and shipment to the retailera�s customer. Protocall Technologies Incorporated was founded in 1998 and is headquartered in Commack, New York. There is a failure to deliver in shares of PCLI.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com